Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection

Persistent severe acute respiratory syndrome coronavirus 2 infection is difficult to treat. Here, we report a case of 5-month persistent coronavirus disease 2019 in an immunocompromised patient who was successfully treated with 30 consecutive days of remdesivir. Prolonged remdesivir infusion with co...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Mario A, Chen, Ting-Yi, Choi, Hosoon, Hwang, Munok, Navarathna, Dhammika, Hao, Linhue, Gale, Michael, Camus, Gregory, Ramirez, Hector E, Jinadatha, Chetan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384609/
https://www.ncbi.nlm.nih.gov/pubmed/36039098
http://dx.doi.org/10.1093/ofid/ofac382
Descripción
Sumario:Persistent severe acute respiratory syndrome coronavirus 2 infection is difficult to treat. Here, we report a case of 5-month persistent coronavirus disease 2019 in an immunocompromised patient who was successfully treated with 30 consecutive days of remdesivir. Prolonged remdesivir infusion with concurrent cycle threshold monitoring might provide a potential solution to cure these patients with difficult-to-treat infections.

Ejemplares similares